Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study
Abstract The impact of the pandemic on hypertension management is unknown, particularly regarding changes in demographic risk factors. We conducted a comprehensive study between 1998 and 2021 on the long-term trends in hypertension prevalence in South Korea, including a comparison of the pre-pandemi...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-12-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-49055-8 |
| _version_ | 1827590566794231808 |
|---|---|
| author | Myeongcheol Lee Hojae Lee Jaeyu Park Hyeon Jin Kim Rosie Kwon Seung Won Lee Sunyoung Kim Ai Koyanagi Lee Smith Min Seo Kim Guillaume Fond Laurent Boyer Masoud Rahmati Sang Youl Rhee Dong Keon Yon |
| author_facet | Myeongcheol Lee Hojae Lee Jaeyu Park Hyeon Jin Kim Rosie Kwon Seung Won Lee Sunyoung Kim Ai Koyanagi Lee Smith Min Seo Kim Guillaume Fond Laurent Boyer Masoud Rahmati Sang Youl Rhee Dong Keon Yon |
| author_sort | Myeongcheol Lee |
| collection | DOAJ |
| description | Abstract The impact of the pandemic on hypertension management is unknown, particularly regarding changes in demographic risk factors. We conducted a comprehensive study between 1998 and 2021 on the long-term trends in hypertension prevalence in South Korea, including a comparison of the pre-pandemic and pandemic eras. Data from 1998 to 2021 of 108,687 Korean adults were obtained through a nationwide, large-scale, and serial study. We conducted a weighted complex sampling analysis on the estimates of national prevalence and compared the slope of hypertension prevalence before and during the pandemic to determine the trend dynamics. We included 108,687 participants over 24 years, 1998–2021. While the prevalence of patients with hypertension consistently increased before the pandemic from 25.51% [95% CI: 24.27–26.75] in 1998–2005 to 27.81% [95% CI: 26.97–28.66] in 2016–2019, the increasing slope in hypertension prevalence slowed during the pandemic period (28.07% [95% CI: 26.16–29.98] for 2021; βdiff, −0.012 [−0.023 to 0.000]). Hypertension awareness, treatment, control, and control rates among patients receiving treatment followed similar trends. Compared to the pre-pandemic era, individuals aged 19–59 years or male had significantly increased control rates among the treated patients during the pandemic. This study investigated long-term trends in hypertension prevalence, awareness, treatment, and control among Korean adults. The absence of a reduction in the health indicators associated with hypertension during the pandemic implies that medical services for individuals with hypertension remain unaffected. |
| first_indexed | 2024-03-09T01:18:38Z |
| format | Article |
| id | doaj.art-7b6b7e15850a45ea9a48990433a62b68 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-09T01:18:38Z |
| publishDate | 2023-12-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-7b6b7e15850a45ea9a48990433a62b682023-12-10T12:17:38ZengNature PortfolioScientific Reports2045-23222023-12-0113111310.1038/s41598-023-49055-8Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial studyMyeongcheol Lee0Hojae Lee1Jaeyu Park2Hyeon Jin Kim3Rosie Kwon4Seung Won Lee5Sunyoung Kim6Ai Koyanagi7Lee Smith8Min Seo Kim9Guillaume Fond10Laurent Boyer11Masoud Rahmati12Sang Youl Rhee13Dong Keon Yon14Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineDepartment of Precision Medicine, Sungkyunkwan University School of MedicineDepartment of Family Medicine, Kyung Hee University Medical Center, Kyung Hee University College of MedicineResearch and Development Unit, Parc Sanitari Sant Joan de DeuCentre for Health, Performance and Wellbeing, Anglia Ruskin UniversityMedical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and HarvardAssistance Publique-Hôpitaux de Marseille, Research Centre on Health Services and Quality of Life, Aix Marseille UniversityAssistance Publique-Hôpitaux de Marseille, Research Centre on Health Services and Quality of Life, Aix Marseille UniversityDepartment of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Vali-E-Asr University of RafsanjanDepartment of Regulatory Science, Kyung Hee UniversityCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of MedicineAbstract The impact of the pandemic on hypertension management is unknown, particularly regarding changes in demographic risk factors. We conducted a comprehensive study between 1998 and 2021 on the long-term trends in hypertension prevalence in South Korea, including a comparison of the pre-pandemic and pandemic eras. Data from 1998 to 2021 of 108,687 Korean adults were obtained through a nationwide, large-scale, and serial study. We conducted a weighted complex sampling analysis on the estimates of national prevalence and compared the slope of hypertension prevalence before and during the pandemic to determine the trend dynamics. We included 108,687 participants over 24 years, 1998–2021. While the prevalence of patients with hypertension consistently increased before the pandemic from 25.51% [95% CI: 24.27–26.75] in 1998–2005 to 27.81% [95% CI: 26.97–28.66] in 2016–2019, the increasing slope in hypertension prevalence slowed during the pandemic period (28.07% [95% CI: 26.16–29.98] for 2021; βdiff, −0.012 [−0.023 to 0.000]). Hypertension awareness, treatment, control, and control rates among patients receiving treatment followed similar trends. Compared to the pre-pandemic era, individuals aged 19–59 years or male had significantly increased control rates among the treated patients during the pandemic. This study investigated long-term trends in hypertension prevalence, awareness, treatment, and control among Korean adults. The absence of a reduction in the health indicators associated with hypertension during the pandemic implies that medical services for individuals with hypertension remain unaffected.https://doi.org/10.1038/s41598-023-49055-8 |
| spellingShingle | Myeongcheol Lee Hojae Lee Jaeyu Park Hyeon Jin Kim Rosie Kwon Seung Won Lee Sunyoung Kim Ai Koyanagi Lee Smith Min Seo Kim Guillaume Fond Laurent Boyer Masoud Rahmati Sang Youl Rhee Dong Keon Yon Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study Scientific Reports |
| title | Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study |
| title_full | Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study |
| title_fullStr | Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study |
| title_full_unstemmed | Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study |
| title_short | Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study |
| title_sort | trends in hypertension prevalence awareness treatment and control in south korea 1998 2021 a nationally representative serial study |
| url | https://doi.org/10.1038/s41598-023-49055-8 |
| work_keys_str_mv | AT myeongcheollee trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT hojaelee trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT jaeyupark trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT hyeonjinkim trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT rosiekwon trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT seungwonlee trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT sunyoungkim trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT aikoyanagi trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT leesmith trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT minseokim trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT guillaumefond trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT laurentboyer trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT masoudrahmati trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT sangyoulrhee trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy AT dongkeonyon trendsinhypertensionprevalenceawarenesstreatmentandcontrolinsouthkorea19982021anationallyrepresentativeserialstudy |